The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2023
DOI: 10.1016/j.ijom.2023.01.019
|View full text |Cite
|
Sign up to set email alerts
|

Xenogeneic collagen matrix versus connective tissue graft for soft tissue augmentation at immediately placed implants: a prospective clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…In the present study, only one soft‐tissue substitute material (VCMX) was tested, but several materials are commercially available. Each material has its specific characteristics in terms of origin, cross‐linked or not, cross‐linking method and structure (Ashurko et al, 2022; Cairo et al, 2017; De Angelis et al, 2023; Tavelli et al, 2022, 2023). Studies regarding those materials generally have shown increased soft‐tissue volume, but such an effect did not surpass autogenous tissue transplant.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the present study, only one soft‐tissue substitute material (VCMX) was tested, but several materials are commercially available. Each material has its specific characteristics in terms of origin, cross‐linked or not, cross‐linking method and structure (Ashurko et al, 2022; Cairo et al, 2017; De Angelis et al, 2023; Tavelli et al, 2022, 2023). Studies regarding those materials generally have shown increased soft‐tissue volume, but such an effect did not surpass autogenous tissue transplant.…”
Section: Discussionmentioning
confidence: 99%
“…A series of clinical studies performed by one research group reported the following main outcomes: (i) non‐inferior tissue profile of a soft‐tissue substitute compared with a CTG, and (ii) stability of the soft‐tissue contour after final prosthesis insertion for up to 5 years (Huber et al, 2018; Thoma et al, 2016, 2020; Thoma, Gasser, et al, 2023; Zeltner et al, 2017). Other investigators have also reported the positive effects of a soft‐tissue substitute in terms of soft‐tissue volume gain, aesthetics, patient satisfaction and peri‐implant health (Cairo et al, 2017; Chappuis et al, 2018; De Angelis et al, 2021, 2023; Sanz‐Martin et al, 2019). In recent large‐scale multi‐centre clinical studies, CTG produced a more favourable soft‐tissue profile than the soft‐tissue substitute, whereas the patients' aesthetic appreciation, Pink Esthetic Score and midfacial recession were similar for the two treatments (Cosyn et al, 2022; Hammerle et al, 2023).…”
Section: Introductionmentioning
confidence: 97%